Success Metrics

Clinical Success Rate
75.0%

Based on 6 completed trials

Completion Rate
75%(6/8)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
2(18%)

Phase Distribution

Ph phase_3
1
9%
Ph not_applicable
4
36%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
4(80.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(6)
Terminated(2)
Other(3)

Detailed Status

Completed6
unknown3
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
75.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (20.0%)
N/A4 (80.0%)

Trials by Status

unknown327%
completed655%
terminated218%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
OTHER
Total Trials
11